FUTURA MEDICAL PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.68 GBX | -0.61% |
|
-1.28% | +43.82% |
| 20/06 | EARNINGS AND TRADING: Lords trading in line; Time Out trading ahead | AN |
| 10/04 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 28.4 | 37.46 | 112.9 | 147.5 | 76.86 | 110.7 | - | - |
| Enterprise Value (EV) 1 | 28.4 | 36.44 | 102.5 | 143.5 | 69.14 | 107.8 | 104.7 | 94.07 |
| P/E ratio | - | -15.4 x | -21.5 x | -25.2 x | - | -36 x | 44.2 x | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 894 x | - | - | - | 24.8 x | 11.6 x | 6.74 x | 4.62 x |
| EV / Revenue | 894 x | - | - | - | 22.3 x | 11.3 x | 6.37 x | 3.93 x |
| EV / EBITDA | - | -12.6 x | -17.5 x | -21 x | - | -105 x | 26.4 x | - |
| EV / FCF | - | -8.01 x | -23.9 x | -22 x | -73.9 x | -24 x | 28.3 x | 12.8 x |
| FCF Yield | - | -12.5% | -4.19% | -4.54% | -1.35% | -4.17% | 3.53% | 7.79% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 2,04,660 | 2,45,627 | 2,87,151 | 2,88,047 | 3,01,406 | 3,01,864 | - | - |
| Reference price 2 | 0.1388 | 0.1525 | 0.3930 | 0.5120 | 0.2550 | 0.3668 | 0.3668 | 0.3668 |
| Announcement Date | 01/04/20 | 14/04/21 | 26/04/22 | 05/04/23 | 10/04/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.0318 | - | - | - | 3.101 | 9.518 | 16.43 | 23.94 |
| EBITDA 1 | - | -2.903 | -5.846 | -6.847 | - | -1.025 | 3.96 | - |
| EBIT 1 | - | -2.928 | -5.866 | -6.871 | -6.964 | -3.128 | 2.226 | 3.834 |
| Operating Margin | - | - | - | - | -224.57% | -32.86% | 13.55% | 16.01% |
| Earnings before Tax (EBT) 1 | - | -2.927 | -5.866 | -6.871 | -6.892 | -2.796 | 2.339 | 4.089 |
| Net income 1 | - | -2.408 | -4.958 | -5.846 | - | -3.072 | 2.497 | - |
| Net margin | - | - | - | - | - | -32.28% | 15.2% | - |
| EPS 2 | - | -0.009900 | -0.0183 | -0.0203 | - | -0.0102 | 0.008300 | - |
| Free Cash Flow 1 | - | -4.552 | -4.293 | -6.516 | -0.9356 | -4.498 | 3.695 | 7.327 |
| FCF margin | - | - | - | - | -30.17% | -47.26% | 22.49% | 30.61% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 93.3% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | 147.99% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 01/04/20 | 14/04/21 | 26/04/22 | 05/04/23 | 10/04/24 | - | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 1.02 | 10.4 | 4.03 | 7.71 | 2.94 | 5.99 | 16.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -4.55 | -4.29 | -6.52 | -0.94 | -4.5 | 3.7 | 7.33 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 0.01 | 0.42 | 0.74 | - | 1.98 | 0.49 | - |
| Capex / Sales | - | - | - | - | - | 20.79% | 2.99% | - |
| Announcement Date | 01/04/20 | 14/04/21 | 26/04/22 | 05/04/23 | 10/04/24 | - | - | - |
1GBP in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.3668
GBP
Average target price
1.263
GBP
Spread / Average Target
+244.47%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +43.82% | 141M | |
| +15.58% | 122B | |
| +16.60% | 113B | |
| +17.55% | 26.22B | |
| -24.33% | 19.01B | |
| -19.14% | 15.71B | |
| -17.95% | 15.22B | |
| -46.81% | 14.72B | |
| +58.78% | 14.58B | |
| +4.91% | 13.84B |
- Stock Market
- Equities
- FUM Stock
- Financials Futura Medical plc
